JVMAX | SPRAX | JVMAX / SPRAX | |
Total Expense Ratio | 1.12 | 1.13 | 99% |
Annual Report Gross Expense Ratio | 1.13 | 1.32 | 86% |
Fund Existence | 28 years | 21 years | - |
Gain YTD | -7.710 | -9.971 | 77% |
Front Load | 5% | 6% | 91% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.6B | 147M | 13,333% |
Annual Yield % from dividends | 0.61 | 1.50 | 41% |
Returns for 1 year | -10.96 | -0.93 | 1,175% |
Returns for 3 years | -8.30 | -1.85 | 449% |
Returns for 5 years | 46.80 | 103.73 | 45% |
Returns for 10 years | 19.44 | 15.84 | 123% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.10 | -0.69% |
YieldMax AMZN Option Income Strategy ETF |